 Jerry Stitzel
Concepts (373)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 64 | 2022 | 273 | 9.760 |
Why?
| | Nicotine | 42 | 2023 | 266 | 7.670 |
Why?
| | Nicotinic Agonists | 15 | 2020 | 100 | 2.750 |
Why?
| | Tobacco Use Disorder | 17 | 2021 | 235 | 2.580 |
Why?
| | Prenatal Exposure Delayed Effects | 5 | 2021 | 447 | 1.640 |
Why?
| | Neurodevelopmental Disorders | 2 | 2021 | 109 | 1.370 |
Why?
| | Polymorphism, Single Nucleotide | 22 | 2023 | 1918 | 1.330 |
Why?
| | Brain | 22 | 2020 | 2370 | 1.310 |
Why?
| | Smoking | 14 | 2023 | 1457 | 1.300 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 12 | 2017 | 96 | 1.100 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 526 | 1.100 |
Why?
| | Polymorphism, Genetic | 12 | 2014 | 621 | 1.090 |
Why?
| | Mice | 56 | 2023 | 15052 | 1.070 |
Why?
| | Hippocampus | 10 | 2019 | 709 | 0.970 |
Why?
| | Mice, Inbred C3H | 15 | 2015 | 244 | 0.930 |
Why?
| | Bungarotoxins | 19 | 2014 | 44 | 0.900 |
Why?
| | Melatonin | 2 | 2015 | 106 | 0.860 |
Why?
| | Protein Subunits | 8 | 2017 | 204 | 0.850 |
Why?
| | Animals | 62 | 2023 | 32102 | 0.830 |
Why?
| | Nerve Tissue Proteins | 9 | 2018 | 535 | 0.760 |
Why?
| | Neurons | 4 | 2018 | 1298 | 0.730 |
Why?
| | Mice, Inbred C57BL | 20 | 2019 | 4773 | 0.730 |
Why?
| | Synaptosomes | 6 | 2014 | 12 | 0.700 |
Why?
| | Mice, Inbred DBA | 17 | 2015 | 173 | 0.690 |
Why?
| | DNA Methylation | 2 | 2021 | 498 | 0.670 |
Why?
| | Frontal Lobe | 2 | 2019 | 139 | 0.660 |
Why?
| | Genetic Variation | 9 | 2022 | 877 | 0.650 |
Why?
| | Nicotinic Antagonists | 7 | 2017 | 20 | 0.650 |
Why?
| | Protein Precursors | 1 | 2019 | 119 | 0.640 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2019 | 106 | 0.640 |
Why?
| | Serine | 1 | 2018 | 125 | 0.610 |
Why?
| | Choice Behavior | 4 | 2015 | 159 | 0.610 |
Why?
| | Gene Expression Regulation | 7 | 2013 | 2353 | 0.600 |
Why?
| | Wakefulness | 1 | 2018 | 128 | 0.600 |
Why?
| | Substance Withdrawal Syndrome | 3 | 2018 | 160 | 0.600 |
Why?
| | Protein Processing, Post-Translational | 1 | 2020 | 401 | 0.590 |
Why?
| | Sleep | 3 | 2018 | 625 | 0.590 |
Why?
| | Species Specificity | 14 | 2012 | 552 | 0.550 |
Why?
| | Motor Activity | 11 | 2022 | 633 | 0.530 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 233 | 0.510 |
Why?
| | Receptors, Melatonin | 1 | 2015 | 2 | 0.500 |
Why?
| | Glucocorticoids | 1 | 2019 | 552 | 0.490 |
Why?
| | Sensory Gating | 1 | 2015 | 38 | 0.480 |
Why?
| | Ethanol | 5 | 2022 | 548 | 0.480 |
Why?
| | Gene Expression | 7 | 2015 | 1435 | 0.480 |
Why?
| | GABA-B Receptor Agonists | 1 | 2014 | 3 | 0.480 |
Why?
| | Receptors, GABA-B | 1 | 2014 | 7 | 0.480 |
Why?
| | Baclofen | 1 | 2014 | 10 | 0.480 |
Why?
| | Alcohol Drinking | 4 | 2022 | 648 | 0.460 |
Why?
| | Drinking | 3 | 2015 | 33 | 0.460 |
Why?
| | Behavior, Animal | 6 | 2019 | 472 | 0.440 |
Why?
| | Polymorphism, Restriction Fragment Length | 6 | 2007 | 65 | 0.440 |
Why?
| | Male | 51 | 2022 | 55949 | 0.430 |
Why?
| | Schizophrenia | 4 | 2017 | 418 | 0.430 |
Why?
| | Circadian Rhythm | 2 | 2015 | 371 | 0.430 |
Why?
| | Acetylcholine | 7 | 2012 | 180 | 0.420 |
Why?
| | Pregnancy | 7 | 2021 | 5548 | 0.420 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 5 | 2018 | 171 | 0.410 |
Why?
| | Female | 50 | 2022 | 59913 | 0.410 |
Why?
| | Calcium | 3 | 2015 | 1103 | 0.400 |
Why?
| | Gene Targeting | 2 | 2011 | 75 | 0.390 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2012 | 1870 | 0.380 |
Why?
| | Mice, Inbred Strains | 9 | 2005 | 399 | 0.370 |
Why?
| | Mice, Knockout | 10 | 2018 | 2604 | 0.370 |
Why?
| | Seizures | 4 | 2007 | 344 | 0.360 |
Why?
| | Pyridines | 5 | 2018 | 425 | 0.360 |
Why?
| | Drug Discovery | 1 | 2011 | 124 | 0.360 |
Why?
| | Administration, Oral | 4 | 2018 | 734 | 0.360 |
Why?
| | Gene Knock-In Techniques | 1 | 2010 | 47 | 0.350 |
Why?
| | Disease Models, Animal | 10 | 2023 | 3580 | 0.350 |
Why?
| | Phenotype | 12 | 2023 | 2829 | 0.340 |
Why?
| | Rubidium | 4 | 2002 | 12 | 0.340 |
Why?
| | Oocytes | 1 | 2010 | 171 | 0.330 |
Why?
| | Signal Transduction | 3 | 2019 | 4541 | 0.320 |
Why?
| | Genetic Predisposition to Disease | 8 | 2022 | 2125 | 0.320 |
Why?
| | Chromosome Mapping | 2 | 2006 | 489 | 0.320 |
Why?
| | Promoter Regions, Genetic | 4 | 2015 | 1122 | 0.320 |
Why?
| | Taste | 2 | 2015 | 208 | 0.310 |
Why?
| | Aging | 2 | 2022 | 1631 | 0.310 |
Why?
| | Brain Chemistry | 2 | 2007 | 116 | 0.300 |
Why?
| | Chlorisondamine | 1 | 2007 | 4 | 0.300 |
Why?
| | Genes, fos | 1 | 2007 | 36 | 0.300 |
Why?
| | Neural Inhibition | 4 | 2017 | 152 | 0.280 |
Why?
| | Mice, Transgenic | 4 | 2018 | 1970 | 0.280 |
Why?
| | Corticosterone | 2 | 2019 | 248 | 0.280 |
Why?
| | Genotype | 14 | 2014 | 1786 | 0.270 |
Why?
| | Microsatellite Repeats | 1 | 2006 | 137 | 0.270 |
Why?
| | Quantitative Trait Loci | 2 | 2015 | 313 | 0.260 |
Why?
| | Anxiety | 1 | 2012 | 853 | 0.260 |
Why?
| | Genome-Wide Association Study | 6 | 2023 | 1217 | 0.250 |
Why?
| | Corpus Striatum | 5 | 2019 | 124 | 0.250 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 10 | 0.250 |
Why?
| | Central Nervous System Depressants | 2 | 2005 | 82 | 0.250 |
Why?
| | Multifactorial Inheritance | 2 | 2023 | 125 | 0.250 |
Why?
| | DNA-Binding Proteins | 2 | 2022 | 1316 | 0.230 |
Why?
| | Up-Regulation | 2 | 2018 | 820 | 0.230 |
Why?
| | Choline | 2 | 2015 | 108 | 0.220 |
Why?
| | Epistasis, Genetic | 1 | 2023 | 69 | 0.210 |
Why?
| | Chronobiology Disorders | 1 | 2022 | 12 | 0.200 |
Why?
| | Maze Learning | 2 | 2012 | 87 | 0.200 |
Why?
| | Tobacco Use | 1 | 2022 | 59 | 0.200 |
Why?
| | Genetic Markers | 2 | 2020 | 325 | 0.200 |
Why?
| | Internationality | 1 | 2022 | 145 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2003 | 187 | 0.200 |
Why?
| | Humans | 38 | 2023 | 115587 | 0.200 |
Why?
| | Quinolizines | 3 | 2010 | 4 | 0.200 |
Why?
| | Azocines | 3 | 2010 | 4 | 0.200 |
Why?
| | Maternal Inheritance | 1 | 2021 | 15 | 0.200 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2014 | 151 | 0.200 |
Why?
| | Alkaloids | 3 | 2010 | 22 | 0.200 |
Why?
| | Alzheimer Disease | 2 | 2022 | 438 | 0.200 |
Why?
| | Varenicline | 2 | 2012 | 21 | 0.190 |
Why?
| | Benzazepines | 2 | 2012 | 37 | 0.190 |
Why?
| | Transcriptome | 2 | 2023 | 736 | 0.190 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 203 | 0.180 |
Why?
| | Quinoxalines | 2 | 2012 | 61 | 0.180 |
Why?
| | Muscle, Skeletal | 1 | 2010 | 1447 | 0.180 |
Why?
| | Dopamine | 3 | 2019 | 237 | 0.180 |
Why?
| | Muscle Proteins | 1 | 2022 | 209 | 0.180 |
Why?
| | Radioligand Assay | 3 | 2012 | 45 | 0.180 |
Why?
| | Histone Deacetylase 2 | 1 | 2020 | 7 | 0.180 |
Why?
| | Methyl-CpG-Binding Protein 2 | 1 | 2020 | 11 | 0.180 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 27 | 0.180 |
Why?
| | Dioxygenases | 1 | 2020 | 25 | 0.170 |
Why?
| | Amino Acid Substitution | 3 | 2009 | 267 | 0.170 |
Why?
| | Cell Line | 6 | 2017 | 2651 | 0.170 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2019 | 17 | 0.170 |
Why?
| | Behavior, Addictive | 1 | 2020 | 78 | 0.170 |
Why?
| | Furin | 1 | 2019 | 13 | 0.170 |
Why?
| | Aequorin | 2 | 2012 | 2 | 0.170 |
Why?
| | Visual Cortex | 1 | 2019 | 41 | 0.170 |
Why?
| | Sexual Maturation | 1 | 2019 | 47 | 0.170 |
Why?
| | Gene-Environment Interaction | 2 | 2018 | 184 | 0.160 |
Why?
| | Sex Factors | 3 | 2012 | 1736 | 0.160 |
Why?
| | Sleep, REM | 1 | 2018 | 50 | 0.160 |
Why?
| | Body Temperature | 7 | 2015 | 211 | 0.160 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2018 | 346 | 0.150 |
Why?
| | Mutation | 4 | 2022 | 3364 | 0.150 |
Why?
| | Down Syndrome | 1 | 2022 | 336 | 0.140 |
Why?
| | Autoradiography | 3 | 2009 | 71 | 0.140 |
Why?
| | Myocarditis | 1 | 2018 | 94 | 0.140 |
Why?
| | Cytochrome P-450 CYP2A6 | 1 | 2016 | 9 | 0.140 |
Why?
| | Acoustic Stimulation | 3 | 2015 | 313 | 0.140 |
Why?
| | Electroencephalography | 1 | 2018 | 365 | 0.140 |
Why?
| | Pyramidal Cells | 1 | 2017 | 51 | 0.140 |
Why?
| | Substance-Related Disorders | 1 | 2005 | 950 | 0.140 |
Why?
| | HEK293 Cells | 3 | 2015 | 602 | 0.140 |
Why?
| | Proto-Oncogene Proteins | 1 | 2020 | 609 | 0.140 |
Why?
| | Alleles | 4 | 2013 | 794 | 0.130 |
Why?
| | Genetic Linkage | 1 | 1996 | 297 | 0.130 |
Why?
| | Cerebral Cortex | 3 | 2009 | 386 | 0.130 |
Why?
| | Cigarette Smoking | 1 | 2016 | 80 | 0.130 |
Why?
| | Time Factors | 5 | 2018 | 6165 | 0.130 |
Why?
| | Receptor, Melatonin, MT1 | 1 | 2015 | 5 | 0.130 |
Why?
| | Mesencephalon | 1 | 2015 | 57 | 0.120 |
Why?
| | Analysis of Variance | 2 | 2012 | 1227 | 0.120 |
Why?
| | Isoxazoles | 1 | 2015 | 56 | 0.120 |
Why?
| | Neurogenesis | 1 | 2015 | 102 | 0.120 |
Why?
| | Autoreceptors | 1 | 2014 | 2 | 0.120 |
Why?
| | Pyrethrins | 1 | 2014 | 6 | 0.120 |
Why?
| | Conotoxins | 2 | 2004 | 4 | 0.120 |
Why?
| | Potassium Chloride | 1 | 2014 | 35 | 0.120 |
Why?
| | Phenylurea Compounds | 1 | 2015 | 83 | 0.120 |
Why?
| | Mycobacterium tuberculosis | 1 | 2017 | 271 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2019 | 794 | 0.120 |
Why?
| | Social Behavior | 1 | 2017 | 269 | 0.120 |
Why?
| | Macrophages, Alveolar | 1 | 2017 | 357 | 0.120 |
Why?
| | Heterozygote | 1 | 2015 | 252 | 0.120 |
Why?
| | Calcineurin Inhibitors | 1 | 2014 | 59 | 0.120 |
Why?
| | Auditory Perception | 1 | 2015 | 101 | 0.120 |
Why?
| | Presynaptic Terminals | 1 | 2014 | 55 | 0.110 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 267 | 0.110 |
Why?
| | Crosses, Genetic | 2 | 2006 | 141 | 0.110 |
Why?
| | Base Sequence | 4 | 2013 | 2114 | 0.110 |
Why?
| | DNA, Intergenic | 1 | 2013 | 23 | 0.110 |
Why?
| | Habituation, Psychophysiologic | 1 | 2014 | 55 | 0.110 |
Why?
| | Haplotypes | 4 | 2018 | 457 | 0.110 |
Why?
| | Patch-Clamp Techniques | 2 | 2004 | 245 | 0.110 |
Why?
| | In Situ Hybridization | 3 | 2003 | 298 | 0.110 |
Why?
| | Sex Characteristics | 3 | 2012 | 641 | 0.110 |
Why?
| | Self Administration | 2 | 2019 | 124 | 0.110 |
Why?
| | 3' Untranslated Regions | 1 | 2013 | 136 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 930 | 0.100 |
Why?
| | Protein Kinase C | 1 | 2014 | 274 | 0.100 |
Why?
| | Permeability | 1 | 2012 | 150 | 0.100 |
Why?
| | Dihydro-beta-Erythroidine | 2 | 2010 | 3 | 0.100 |
Why?
| | In Vitro Techniques | 3 | 2003 | 1044 | 0.100 |
Why?
| | Rubidium Radioisotopes | 4 | 2004 | 4 | 0.100 |
Why?
| | Myocardial Infarction | 1 | 2018 | 931 | 0.100 |
Why?
| | Alcoholism | 3 | 2008 | 713 | 0.100 |
Why?
| | Transfection | 3 | 2013 | 866 | 0.090 |
Why?
| | Statistics as Topic | 1 | 2012 | 299 | 0.090 |
Why?
| | Food Preferences | 1 | 2012 | 108 | 0.090 |
Why?
| | Gene Frequency | 2 | 2009 | 485 | 0.090 |
Why?
| | Iodine Radioisotopes | 2 | 2009 | 126 | 0.090 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 324 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2000 | 0.090 |
Why?
| | Decamethonium Compounds | 1 | 2010 | 1 | 0.090 |
Why?
| | Hexamethonium | 1 | 2010 | 4 | 0.090 |
Why?
| | Mecamylamine | 1 | 2010 | 8 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 795 | 0.090 |
Why?
| | Animals, Newborn | 1 | 2012 | 780 | 0.090 |
Why?
| | Genetic Association Studies | 3 | 2018 | 343 | 0.080 |
Why?
| | Xenopus laevis | 1 | 2010 | 118 | 0.080 |
Why?
| | Electrophysiology | 1 | 2010 | 202 | 0.080 |
Why?
| | Organ Specificity | 1 | 2010 | 273 | 0.080 |
Why?
| | Rats | 5 | 2013 | 5034 | 0.080 |
Why?
| | Dithiothreitol | 2 | 1988 | 17 | 0.080 |
Why?
| | Risk | 3 | 2019 | 819 | 0.080 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2008 | 28 | 0.080 |
Why?
| | Luciferases | 3 | 2013 | 140 | 0.080 |
Why?
| | Epilepsy | 2 | 2012 | 290 | 0.080 |
Why?
| | Columbidae | 1 | 2007 | 32 | 0.070 |
Why?
| | Europe | 2 | 2022 | 336 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2015 | 2574 | 0.070 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 107 | 0.070 |
Why?
| | Mice, Congenic | 1 | 2006 | 21 | 0.070 |
Why?
| | Lod Score | 1 | 2006 | 65 | 0.070 |
Why?
| | RNA | 2 | 2010 | 819 | 0.070 |
Why?
| | Drug Interactions | 2 | 2004 | 347 | 0.070 |
Why?
| | Adult | 12 | 2016 | 30718 | 0.070 |
Why?
| | Thalamus | 2 | 2009 | 78 | 0.060 |
Why?
| | Age of Onset | 2 | 2020 | 450 | 0.060 |
Why?
| | Drinking Behavior | 1 | 2005 | 10 | 0.060 |
Why?
| | Reflex, Startle | 5 | 2017 | 58 | 0.060 |
Why?
| | Cadmium Chloride | 1 | 2004 | 4 | 0.060 |
Why?
| | Algorithms | 1 | 2012 | 1490 | 0.060 |
Why?
| | Ryanodine | 1 | 2004 | 13 | 0.060 |
Why?
| | Macrocyclic Compounds | 1 | 2004 | 9 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 2907 | 0.060 |
Why?
| | Middle Aged | 9 | 2019 | 26999 | 0.060 |
Why?
| | Oxazoles | 1 | 2004 | 29 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 77 | 0.060 |
Why?
| | Snails | 1 | 2004 | 32 | 0.060 |
Why?
| | Risk Factors | 5 | 2022 | 8697 | 0.060 |
Why?
| | Binding, Competitive | 3 | 2003 | 200 | 0.060 |
Why?
| | Extracellular Space | 1 | 2004 | 122 | 0.060 |
Why?
| | Membrane Potentials | 1 | 2004 | 251 | 0.060 |
Why?
| | Tobacco Products | 2 | 2019 | 99 | 0.060 |
Why?
| | Mice, 129 Strain | 2 | 2015 | 77 | 0.060 |
Why?
| | Sequence Analysis | 1 | 2003 | 35 | 0.060 |
Why?
| | Threonine | 1 | 2003 | 40 | 0.060 |
Why?
| | Electroporation | 1 | 2003 | 32 | 0.060 |
Why?
| | Alanine | 1 | 2003 | 103 | 0.050 |
Why?
| | Tobacco Smoking | 1 | 2023 | 21 | 0.050 |
Why?
| | Sequence Alignment | 1 | 2003 | 327 | 0.050 |
Why?
| | Exons | 1 | 2003 | 300 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 115 | 0.050 |
Why?
| | Luminescent Proteins | 1 | 2003 | 169 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2010 | 2800 | 0.050 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2022 | 19 | 0.050 |
Why?
| | Adolescent | 7 | 2019 | 17889 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2003 | 377 | 0.050 |
Why?
| | DNA | 3 | 2010 | 1356 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 231 | 0.050 |
Why?
| | Biological Transport, Active | 1 | 2001 | 71 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 757 | 0.050 |
Why?
| | Genetic Loci | 1 | 2022 | 264 | 0.050 |
Why?
| | Serum Albumin, Bovine | 1 | 2001 | 65 | 0.050 |
Why?
| | Interneurons | 1 | 2001 | 99 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2001 | 258 | 0.050 |
Why?
| | Blotting, Western | 1 | 2003 | 1153 | 0.050 |
Why?
| | Injections, Intraventricular | 1 | 2000 | 72 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1646 | 0.050 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 104 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2004 | 2790 | 0.040 |
Why?
| | Odds Ratio | 2 | 2016 | 962 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 66 | 0.040 |
Why?
| | Hybridization, Genetic | 1 | 2000 | 77 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2005 | 573 | 0.040 |
Why?
| | Hyperkinesis | 1 | 2019 | 11 | 0.040 |
Why?
| | Gene Transfer Techniques | 1 | 2000 | 148 | 0.040 |
Why?
| | Methylphenidate | 1 | 2019 | 36 | 0.040 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 40 | 0.040 |
Why?
| | Cattle | 1 | 2001 | 935 | 0.040 |
Why?
| | Protective Factors | 1 | 2018 | 87 | 0.040 |
Why?
| | Linkage Disequilibrium | 2 | 2009 | 247 | 0.040 |
Why?
| | Young Adult | 4 | 2016 | 10470 | 0.040 |
Why?
| | Protein Binding | 1 | 2003 | 1917 | 0.040 |
Why?
| | Autophagosomes | 1 | 2017 | 19 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 1999 | 1168 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2015 | 2751 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2018 | 3914 | 0.040 |
Why?
| | Prepulse Inhibition | 1 | 2017 | 9 | 0.040 |
Why?
| | Inflammasomes | 1 | 2018 | 116 | 0.040 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2017 | 42 | 0.040 |
Why?
| | Kinetics | 4 | 2004 | 1569 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2009 | 2207 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 1996 | 163 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2017 | 81 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 370 | 0.030 |
Why?
| | Binding Sites | 3 | 2007 | 1177 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2017 | 398 | 0.030 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2015 | 53 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2018 | 479 | 0.030 |
Why?
| | Autophagy | 1 | 2017 | 236 | 0.030 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 362 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2017 | 342 | 0.030 |
Why?
| | Transcription Factors | 1 | 2022 | 1528 | 0.030 |
Why?
| | DNA Primers | 2 | 2008 | 514 | 0.030 |
Why?
| | Mice, Inbred AKR | 2 | 2003 | 34 | 0.030 |
Why?
| | Mice, Inbred A | 2 | 2003 | 45 | 0.030 |
Why?
| | NF-kappa B | 1 | 2017 | 639 | 0.030 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2013 | 74 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 867 | 0.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1098 | 0.030 |
Why?
| | Lactation | 1 | 2014 | 149 | 0.030 |
Why?
| | Down-Regulation | 1 | 2015 | 601 | 0.030 |
Why?
| | Aged | 3 | 2018 | 19251 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2008 | 1000 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2015 | 6417 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2010 | 3022 | 0.030 |
Why?
| | Adolescent Development | 1 | 2012 | 83 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1284 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2499 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4113 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3339 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2014 | 458 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2012 | 163 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 345 | 0.020 |
Why?
| | Dizziness | 1 | 2010 | 70 | 0.020 |
Why?
| | Ligands | 2 | 2003 | 569 | 0.020 |
Why?
| | Respiration | 3 | 2002 | 177 | 0.020 |
Why?
| | Heart Rate | 4 | 2002 | 701 | 0.020 |
Why?
| | Receptors, Muscarinic | 1 | 1989 | 18 | 0.020 |
Why?
| | Alkylation | 1 | 1988 | 19 | 0.020 |
Why?
| | Pharmacogenetics | 1 | 1989 | 151 | 0.020 |
Why?
| | Disulfides | 1 | 1988 | 91 | 0.020 |
Why?
| | Receptors, Opioid | 1 | 1987 | 19 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2008 | 309 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 116 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 355 | 0.020 |
Why?
| | Family Health | 1 | 2008 | 195 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 6264 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 499 | 0.020 |
Why?
| | MicroRNAs | 1 | 2013 | 607 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1086 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2007 | 156 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1700 | 0.020 |
Why?
| | Nucleus Accumbens | 1 | 2007 | 123 | 0.020 |
Why?
| | Logistic Models | 1 | 2010 | 1856 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 1988 | 924 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2578 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2015 | 5077 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2008 | 1440 | 0.010 |
Why?
| | Receptors, Neurotransmitter | 1 | 2003 | 15 | 0.010 |
Why?
| | Substantia Nigra | 1 | 2003 | 37 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2004 | 523 | 0.010 |
Why?
| | Genomics | 1 | 2008 | 645 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 377 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2003 | 271 | 0.010 |
Why?
| | Infant | 1 | 2015 | 7979 | 0.010 |
Why?
| | Drug Tolerance | 3 | 1987 | 79 | 0.010 |
Why?
| | United States | 1 | 2018 | 12295 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 616 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 9133 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1243 | 0.010 |
Why?
| | Cell Count | 1 | 2001 | 305 | 0.010 |
Why?
| | Veratridine | 1 | 2000 | 7 | 0.010 |
Why?
| | Stimulation, Chemical | 1 | 2000 | 57 | 0.010 |
Why?
| | Potassium | 1 | 2000 | 128 | 0.010 |
Why?
| | Cohort Studies | 1 | 2009 | 4944 | 0.010 |
Why?
| | Genetic Testing | 1 | 2001 | 382 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2001 | 1642 | 0.010 |
Why?
| | Child | 1 | 2015 | 18488 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 9159 | 0.010 |
Why?
| | Quinuclidinyl Benzilate | 1 | 1989 | 2 | 0.010 |
Why?
| | Dithionitrobenzoic Acid | 1 | 1986 | 1 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1986 | 376 | 0.000 |
Why?
| | Infusions, Intravenous | 1 | 1987 | 374 | 0.000 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 109 | 0.000 |
Why?
| | Hot Temperature | 1 | 1986 | 303 | 0.000 |
Why?
| | Oxygen Consumption | 1 | 1986 | 573 | 0.000 |
Why?
|
|
Stitzel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|